Bristol-Myers Squibb (BMY) Tops Q4 EPS by 9c, Offers FY19 Guidance
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $63.06 +0.35%
Revenue Growth %: +3.2%
Financial Fact:
Net Earnings: 1.22B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +3.2%
Financial Fact:
Net Earnings: 1.22B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $0.94, $0.09 better than the analyst estimate of $0.85. Revenue for the quarter came in at $5.97 billion versus the consensus estimate of $5.99 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2019 EPS of $4.10-$4.20, versus the consensus of $4.14.
- Worldwide revenues increasing in the mid-single digits.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb Co. (BMY) PT Raised to $82 at Piper Sandler
- Faeth Therapeutics adds cancer biologist Karen Vousden to its board
- Corpay agrees to $100M FTC settlement over marketing practices
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
